|
HemaCare Corporation, founded in 1978, and its subsidiary, Coral Blood Services, provides blood products and services to over 160 hospitals in Southern California and the East Coast. It is publicly held, licensed by the
Food and Drug Administration (FDA), and is accredited by the American Association of Blood Banks (AABB).
Since its inception, HemaCare/Coral Blood Services has produced over 110,000 single donor platelet/pheresis blood products and has performed over 50,000 therapeutic apheresis treatments.
|
|
With a focus on improved patient care, donor convenience and reduced costs, HemaCare/Coral Blood Services has been successful in operating and managing customized blood donor programs. These programs include the following
activities:
- Specialized blood collection and services, including single donor platelets, plasma and red blood cell collection, stem cell harvesting/cryopreservation, therapeutic apheresis, leukapheresis and support services for
research programs
- Hospital-based blood donor facility, where physicians refer patients and friends/families for autologous and directed donations
- Community blood drives to develop local blood resources
- Donor testing and whole blood product manufacturing
|